Low-Molecular-Weight Heparin for Acute Stroke Patients with Large Artery Occlusive Disease "FISS-tris"

Completed

Phase N/A Results

Summary of Purpose

To determine if fraxiparine(low molecular weight heparin) is superior to aspirin in improving stroke outcome at 6 months in acute ischemic stroke patients with large artery occlusive disease.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Clinical Effectiveness Unit, Hospital Authority in Hong Kong, the National Medical Research Council of Singapore (NMRC/0691/2002), and the Clinical Trials and Epidemiology Research Unit, Singapore

Trial Design

Randomized, international, multi-center, controlled trial.

Contacts

Not available